Loading…
Distacart Inc. was found to be selling nine unapproved drug products through its website, including homeopathic remedies and eye drops that made claims to treat serious conditions such as malaria, depression, asthma, and measles without FDA approval, in violation of sections 301(d) and 505(a) of the FD&C Act. The company's products posed particular public health concerns because they made therapeutic claims for life-threatening diseases that could cause consumers to delay or forgo proven medical treatments, and because several ophthalmic products presented elevated safety risks due to direct eye administration bypassing natural body defenses.